Skip to main content
. 2015 Dec 2;2015(12):CD009172. doi: 10.1002/14651858.CD009172.pub2

Comparison 2. MFS‐LE versus S‐LE.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Death before discharge 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 5.00 [0.25, 99.95]
2.2 Days to regain birth weight 1 57 Mean Difference (IV, Fixed, 95% CI) ‐1.00 [‐3.60, 1.60]
2.3 Rate of weight gain (g/kg/day) 1 57 Mean Difference (IV, Fixed, 95% CI) ‐1.67 [‐7.01, 3.67]
2.4 Bronchopulmonary dysplasia/chronic lung disease 1 57 Risk Ratio (M‐H, Fixed, 95% CI) 1.39 [0.42, 4.65]
2.5 Any sepsis (clinical and/or culture positive) 1 57 Risk Ratio (M‐H, Fixed, 95% CI) 1.11 [0.31, 4.02]
2.6 Necrotising enterocolitis (≥ stage 2) 1 57 Risk Difference (M‐H, Fixed, 95% CI) 0.00 [‐0.07, 0.07]
2.7 Any patent ductus arteriosus 1 57 Risk Ratio (M‐H, Fixed, 95% CI) 0.96 [0.57, 1.64]
2.8 Parenteral nutrition associated liver disease/cholestasis 1 57 Risk Ratio (M‐H, Fixed, 95% CI) 3.32 [0.14, 78.25]